Dr Kyle Hoehn is an Associate Professor in the School of Biotechnology and Biomolecular Sciences at the University of New South Wales. Kyle received a PhD in Biochemistry from Colorado State University in 2005, and completed postdoctoral training at the Garvan Institute of Medical Research in Sydney in 2009. He established an independent research laboratory at the University of Virginia in 2009 and moved his laboratory to UNSW in 2014. His research program centres on obesity and its related disorders including cancers of the liver and endometrium.
Abstracts this author is presenting: